AstraZeneca and Trump Team Up to Lower Drug Prices
TL;DR Summary
AstraZeneca CEO Pascal Soriot successfully negotiated a significant US medicine deal with President Trump, which included lowering drug prices and establishing a US manufacturing plant, shielding the company from tariffs and boosting its US presence, amid broader US efforts to reduce drug costs and attract pharmaceutical investments.
- Banquets and billions: How AstraZeneca sealed a US medicine deal with Trump Reuters
- Donald Trump’s Big Pharma Showdown Ends with a Whimper The New Yorker
- Trump reveals prescription drug deal with pharmaceutical giant AstraZeneca Al Jazeera
- AstraZeneca makes deal with White House to lower drug prices NPR
- Watch: Trump to give announcement on lowering drug prices The Hill
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
5 min
vs 6 min read
Condensed
96%
1,143 → 47 words
Want the full story? Read the original article
Read on Reuters